vioxx

19 Sep: Murkier and murkier for Merck

From the Daily Dog: The state and city of New York filed suit this week against Merck, claiming the drugmaker concealed the risks of the withdrawn arthritis treatment Vioxx. The lawsuit seeks damages, penalties and restitution for “tens of millions of taxpayer dollars wrongfully spent on Vioxx prescriptions,” the office of New York State Attorney General Andrew Cuomo said in a statement… “Merck’s irresponsible and duplicitous conduct endangered the health of New Yorkers and wasted our tax dollars,” Cuomo said… The Attorney General’s office said this is the first case to be brought under New York’s recently-enacted False Claims Act, which allows the state to seek damages for the amount spent in Medicaid and EPIC healthcare programs to pay for…

27 Aug: Vioxx lesson: When you’re bad, be VERY bad

Remember the little problem with Vioxx? As a result, Vioxx still has more than 13,800 lawsuits on the docket. Over the last two years, only four trials have been held, but Judge Carol Higbee is looking to pick up the pace — from glacier slow to snail-in-winter slow. Higbee’s goal, according to Pharmalot, is to “ease the logjam”. But Pharmalot points out: With so many lawsuits, it’s entirely possible that many of the Vioxx plaintiffs will never see their day in court, or collect if they do win, because Merck is appealing every outcome that doesn’t go its way. For this reason, Wall Street believes Merck’s Vioxx liability is $5 billion, not the $25 billion or more that many once…